自从1977年Shearing 氏后房型人工晶体问世以来,后房型人工晶体植入获得了飞跃的发展。我院从1985年开始将透明硅凝胶后房型人工晶体植入人眼,取得令人鼓舞的效果,现将术后观察了三个月以上的27例做以下报告,并就其主要并发症做简要的讨论。临床资料一、我们采用成都蜀光生物医学工程技术研究所提供的透明硅凝胶后房型人工晶体(PC 型),27例均为白内障单眼患者,都是一期植入。27例中男性16例,女性11例;最大年龄76岁,最小19岁;老年性白 Since the advent of Shearing’s posterior chamber intraocular lenses in 1977, posterior chamber intraocular lens implantation has leapfrogged. Our hospital from 1985, the transparent silicone gel posterior chamber intraocular lens implantation in the human eye, achieved encouraging results, are now observed after more than three months in 27 cases to do the following report, and its main complications Do a brief discussion. Clinical data First, we use Chengdu Shu Guang Biomedical Engineering Institute provided transparent silicone gel posterior chamber intraocular lens (PC type), 27 cases were cataract patients with monocular, are a period of implantation. 27 cases of male 16 cases, 11 females; maximum age 76 years, minimum 19 years old; white age